Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.
Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance.
复制标题
卵巢癌中路易斯Y抗原和整联蛋白αV,β3的表达及其与化学耐药性的关系。
DOI:
10.1186/1756-9966-32-36
复制
发表时间:
2013-06-01
期刊:
影响因子:
--
通讯作者:
Lin B
中科院分区:
文献类型:
--
作者:
Gao J;Hu Z;Liu D;Liu J;Liu C;Hou R;Gao S;Zhang D;Zhang S;Lin B
This study investigates the expression of Lewis y antigen, integrin αv, β3 in epithelial ovarian cancer tissues. We further evaluate the relationship between their expression and chemotherapy resistance of ovarian cancer and its possible clinical significance. Tissues of 92 patients with ovarian cancer meeting the inclusion criteria with complete follow-up data were enrolled and divided into chemotherapy resistant group and sensitive group. The expression and relationship of Lewis y antigen and integrin αv, β3 are assessed in paraffin sections using immunohistochemistry and double-labeling immunofluorescence method. Multivariate logistic regression analysis was used to investigate the relationship between age, clinical stage, differentiation, histologic subtype, Lewis y antigen and integrin αv, β3 expression in ovarian cancer patients. The expression rates of Lewis y antigen and integrin αv in the resistant group, significantly higher than the rates found in the sensitive group (p <0.05). Multivariate analysis showed that the expression of Lewis y antigen, integrin αv and ovarian cancer’s clinical stage were independent, drug resistance-related risk factors. The expression levels of Lewis y antigen and integrin αv, β3 were positively correlated with each other. A close correlation between Lewis y antigen, integrin αv, β3 and ovarian cancer was observed. Lewis y antigen can influence the biological behavior of a tumor cell as an important composition of integrin αv, β3 by some signal pathway. And the expression of Lewis y antigen, integrin αv and ovarian cancer’s clinical stage are both independent, drug resistance-related risk factors.
登录
查看更多内容
影响因子:
5.6
作者:
Wang Y;Liu J;Lin B;Wang C;Li Q;Liu S;Yan L;Zhang S;Iwamori M
通讯作者:
Iwamori M
影响因子:
20.3
作者:
Damiano, JS;Cress, AE;Dalton, WS
通讯作者:
Dalton, WS
DOI:
10.1111/igc.0b013e3181ea7ecb
发表时间:
2010-12-01
影响因子:
4.8
作者:
Li, Quanrong;Liu, Shuice;Zhang, Shulan
通讯作者:
Zhang, Shulan
影响因子:
4.8
作者:
Zhao, Yanyang;Itoh, Satsuki;Gu, Jianguo
通讯作者:
Gu, Jianguo
影响因子:
5.6
作者:
Zhang F;Liu J;Lin B;Liu Q;Zhao Y;Zhu L;Hao Y;Zhang S;Iwamori M
通讯作者:
Iwamori M